In Episode 2 of our 'Tea and Talk' podcast, Dr. Rebekah Widdowfield chats with the CEO of Novabiotics, Dr. Deborah O'Neil about the efficacy of creating drugs, how the vaccine development process works, current efforts being made to produce treatments for COVID-19, and how the current pandemic has affected our approach to global production and collaboration.
Subscribe for a new episode every Friday.
The Royal Society of Edinburgh — @news_RSE
Dr. Rebekah Widdowfield — @Rebekah_RSE
Dr. Deborah O'Neil — @debsoneil | @NovaBiotics
Studies have shown that living with a disability is more expensive than living without one. As the Covid-19 pandemic has dealt a huge blow...
'Tea and Talk' returns for Episode 4 with Dr. Stella Chan of the University of Edinburgh, and a member of the RSE Young Academy...
Welcome back for another series of the Royal Society of Edinburgh's 'Tea & Talk' Podcast; a series of conversations with some of Scotland's leading...